Angiolite
Commercial- Indications
- Coronary artery disease
Company intelligence / Profile preview
iVascular has achieved CE marking for over thirty vascular medical devices—including drug-eluting stents—and markets these globally. The company controls the full product lifecycle from raw materials to finished product and continues to expand into neurointerventional and structural heart device areas. It operates advanced R&D and manufacturing facilities in Barcelona. No specific clinical trial results are detailed in the available sources.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iVascular.